Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
02.04.2025 08:00:06

EQS-News: Michael Köhler and Stephan Weber nominated for the Supervisory Board of Redcare Pharmacy.

EQS-News: Redcare Pharmacy N.V. / Key word(s): AGM/EGM
Michael Köhler and Stephan Weber nominated for the Supervisory Board of Redcare Pharmacy.

02.04.2025 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


Michael Köhler and Stephan Weber nominated for the Supervisory Board of Redcare Pharmacy.

Sevenum, 2 April 2025. At Redcare Pharmacy’s upcoming Annual General Meeting (AGM) on 15 May 2025, changes to the composition of the Supervisory Board will be on the agenda. Redcare Pharmacy nominates the company’s founders and former board members Michael Köhler and Stephan Weber to succeed Frank Köhler and Henriette Peucker, who have decided to leave at the end of their current terms.

Björn Söder, Chairman of the Supervisory Board, comments: "I would like to express my sincere gratitude to Henriette and Frank. Their expertise and dedication have played a key role in driving Redcare's success.  As chair of the Nomination Committee, Henriette was central to shaping the current composition of the Managing Board. During her tenure, an external CEO search and the internal succession of the CCO and CIO were completed. Frank’s long-standing tenure, along with his profound financial expertise and business acumen, has been crucial for the development of Redcare from a start-up to Europe’s leading online pharmacy. At the same time, I am excited to welcome back Michael and Stephan – two individuals who embody true entrepreneurial spirit and bring considerable industry knowledge to the Supervisory Board. With his proven track record in the scaling of e-commerce initiatives, Stephan will be an ideal addition to help drive the company’s next growth phase. Coupled with Michael's strategic mindset as well as his extensive Rx online pharmacy and pharma industry expertise, both new members will be invaluable assets as we continue to advance our long-term strategy."

Alongside the nomination of Michael Köhler and Stephan Weber, it is proposed to re-appoint Jérôme Cochet for a term of one year. Subject to the approval of the Annual General Meeting, the Supervisory Board will consist of Björn Söder (Chairman), Jaska de Bakker (Deputy Chairwoman), Jérôme Cochet, Michael Köhler and Stephan Weber.

The convocation of the AGM has been published on the company's website today.

 

Investor Relations Contact:

Monica Ambrosi (Associate Director, Investor Relations)

investors@redcare-pharmacy.com

 

Press Contact:

Sven Schirmer (Director, Corporate Communications)

press@redcare-pharmacy.com

 

About Redcare Pharmacy.

Originally founded in 2001, Redcare Pharmacy N.V. (formerly known as Shop Apotheke Europe N.V.) today is the leading e-pharmacy in Europe, currently active in seven countries: Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.

Headquartered in Sevenum, close to the Dutch city of Venlo and in the heart of Europe, the company has locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Lille and Eindhoven.

As the one-stop pharmacy of the future, Redcare Pharmacy offers 12.5 million active customers a wide range of more than 250,000 products at attractive and fair prices. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands.

Pharmaceutical safety is of top priority. Being a pharmacy at its core, Redcare stands for comprehensive pharmaceutical consultation service. Since care is at the heart of everything Redcare does, the company provides services for all stages of life and health. This ranges from its marketplaces to unique delivery options and medication management.

Redcare Pharmacy N.V. has been listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard) since 2016. As of 19 June 2023, the company is a member of the MDAX selection index.

 



02.04.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Redcare Pharmacy N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: investors@redcare-pharmacy.com
Internet: www.redcare-pharmacy.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y072
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2110240

 
End of News EQS News Service

2110240  02.04.2025 CET/CEST

Analysen zu Redcare Pharmacy (ex Shop Apotheke)

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
14:30 Redcare Pharmacy Buy Jefferies & Company Inc.
31.03.25 Redcare Pharmacy Buy Deutsche Bank AG
21.03.25 Redcare Pharmacy Buy Baader Bank
14.03.25 Redcare Pharmacy Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
12.03.25 Redcare Pharmacy Buy Deutsche Bank AG
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Investieren in Rüstungsaktien – Wall Street Live mit Tim Schäfer

Tim Schäfer analysiert im Gespräch mit David Kunz (COO der BX Swiss) die spannendsten Defense-Aktien aus Europa und den USA. Sind Rheinmetall, Palantir oder Lockheed Martin noch kaufenswert – oder schon überbewertet?
Wir sprechen über die Rolle von Trumps NATO-Druck, die massive Aufrüstung in Europa und warum gerade europäische Rüstungsaktien boomen.

✅ Top-Performer 2024
✅ Value- und Dividenden-Checks
✅ Geheimtipps wie BAE Systems, Thales & Co.
✅ Palantir als digitaler Profiteur

In unserem zweiwöchigen Format „Wall Street Live“ mit Tim Schäfer behandeln wir Topaktuelle Themen des Marktgeschehens.
🛑 Wichtig: Das Thema Rüstung ist gesellschaftlich wie ethisch komplex – in diesem Video beleuchten wir vor allem die börsentechnische Entwicklung und die wirtschaftlichen Auswirkungen globaler Ereignisse.

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Investieren in Rüstungsaktien – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’110.50 13.56 BHDSPU
Short 13’575.56 8.94 UEBSLU
SMI-Kurs: 12’307.77 03.04.2025 15:56:32
Long 11’800.00 19.69
Long 11’545.97 13.86 BGLSFU
Long 11’051.95 8.91 SSSMQU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}